Description
Product Classification: Research-Use-Only (RUO)
Total Content: 10 mg lyophilized powder per vial
Compound: Mazdutide research analog
Form: Sterile lyophilized peptide compound
Purity: ≥99%
Storage: Store at −20 °C, protected from light
Packaging: Glass vial in protective sleeve
Description
Mazdutide 10 mg is a mazdutide research analog designed for laboratory investigation of dual receptor signaling pathways. Mazdutide is studied as a dual receptor agonist model involving GLP-1 receptor and glucagon receptor pathway activity. This dual-pathway profile makes it useful for preclinical research into metabolic regulation, energy balance, glucose signaling, receptor cross-talk, and metabolic pathway modeling.
This compound is intended strictly for in vitro and preclinical laboratory research.
Applications
Intended for preclinical laboratory research only, including:
- GLP-1 receptor signaling studies
- Glucagon receptor pathway research
- Dual receptor pathway analysis
- Metabolic regulation investigations
- Energy-balance pathway studies
- Glucose signaling experiments
- Comparative metabolic analog research
WARNING: Not for human or animal use. For research purposes only.
SCIENTIFIC REPORT
Abstract
Mazdutide is a synthetic dual receptor agonist investigated for activity at GLP-1 and glucagon receptors. This dual-pathway profile allows researchers to model complementary metabolic signaling systems in controlled experimental environments. Mazdutide 10 mg is designed for laboratory use in studies examining metabolic signaling, receptor selectivity, energy regulation, glucose pathway activity, and downstream cellular responses associated with dual receptor activation.
Mechanistic Pathway
Mazdutide is designed around dual receptor pathway modeling.
- GLP-1 Receptor Pathway
- Supports research into incretin signaling
- Used in glucose-regulatory pathway models
- Studied for effects on downstream metabolic signaling
- Effect: Models GLP-1 receptor activity in controlled research systems.
- Glucagon Receptor Pathway
- Supports investigation of glucagon-associated signaling
- Used in energy-regulation and metabolic pathway models
- Helps study receptor cross-talk in metabolic systems
Effect: Enables research into glucagon receptor contribution to dual-pathway metabolic signaling.
Dual Receptor Signaling Pathway
- Supports research into combined incretin and glucagon receptor activity
- Used in metabolic regulation and glucose signaling models
- Helps evaluate interaction between complementary receptor pathways
- Effect: Provides a model for dual receptor pathway regulation research.
- Pharmacokinetics / Research Profile
- Compound
- Pathway
- Research Notes
- Mazdutide analog
- GLP-1R / GCGR
- Dual receptor agonist model for metabolic pathway research
Dosing Models in Research
Used only in controlled in vitro and preclinical research models to study receptor signaling and metabolic pathway response. No human or animal-use instructions are provided.
Preclinical Research Highlights
- Studied as a dual agonist model involving GLP-1 and glucagon receptors
- Used in metabolic regulation and energy-balance pathway research
- Supports comparative studies with single and dual receptor metabolic models
- Relevant to glucose signaling, receptor interaction, and pathway cross-talk studies
- Useful for evaluating downstream effects of dual-receptor peptide signaling
Conclusion
Mazdutide 10 mg offers a research-use-only model for studying dual receptor pathway activation. By engaging GLP-1 and glucagon receptor signaling models, it supports advanced preclinical investigation into metabolic regulation, receptor cross-talk, glucose pathway signaling, energy balance, and dual receptor pathway interactions.
